Search results for “DPP-4 Inhibitors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 587 patents, we discovered top 55 key players by total patent application. Boehringer Ingelheim International GmbH, Merck Sharp & Dohme Corp., Eli Lilly & Co. are dominant in this area. They take 76.83% of the total patent filing.
Rheinland-Pfalz, Germany
Patent: 397
New Jersey, United States
Patent: 43
Indiana, United States
Patent: 11
New Jersey, United States
Patent: 8
Osaka-fu, Japan
Patent: 8
Shanghai Shi, China
Patent: 8
Tokyo-to, Japan
Patent: 7
South Korea
Patent: 7
United States
Patent: 7
Alberta, Canada
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 44 patents applied in the last 5 years. We discover 21 most active companies in this area. The fast-growing Boehringer Ingelheim International GmbH, Resverlogix Corp., Shanghai Institute of Materia Medica Chinese Academy of Sciences take 47.73% of patent filing during this period.
Rheinland-Pfalz, Germany
Patent: 13
Alberta, Canada
Patent: 6
Shanghai Shi, China
Patent: 2
Hunan Sheng, China
Patent: 2
South Korea
Patent: 2
India
Patent: 1
Brandenburg, Germany
Patent: 1
undefined undefined
Patent: 1
Qatar
Patent: 1
Shanghai Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 44 patents in last 5 years, we discover 16 new entrants. Resverlogix Corp., Hunan University of Science & Technology, NovMetaPharma Co., Ltd. are the most active new entrants in this area.
Alberta, Canada
Patent: 6
Hunan Sheng, China
Patent: 2
South Korea
Patent: 2
India
Patent: 1
Brandenburg, Germany
Patent: 1
undefined undefined
Patent: 1
Qatar
Patent: 1
Shanghai Shi, China
Patent: 1
Shaanxi Sheng, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 55 patents, we discovered top 12 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, East China University of Science & Technology, Shanghai Institute of Pharmaceutical Industry are dominant in this area. They take 56.36% of the total patent filing.
Shanghai Shi, China
Patent: 13
Shanghai Shi, China
Patent: 10
Shanghai Shi, China
Patent: 8
Jiangsu Sheng, China
Patent: 3
Shanghai Shi, China
Patent: 2
Hunan Sheng, China
Patent: 2
Guangdong Sheng, China
Patent: 1
Georgia, United States
Patent: 1
Fukuoka-ken, Japan
Patent: 1
Hunan Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: